See Yourself Health LLC received a $612,981 project grant award from the National Institute on Aging, part of the Department of Health and Human Services, under the Aging Research program (CFDA 93.866). The grant funds the development of an immersive telehealth solution called the HOPE App, designed to deliver diabetes self-management education and support tailored for older adults with diabetes. The HOPE App will consist of 28 educational modules and maintenance programming delivered through...
This federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research, aims to develop a culturally adapted digital health application for older Hispanic patients with type 2 diabetes. The $376,208 award will fund the refinement and modernization of a previously developed health intervention prototype into a user-friendly, secure digital app. The app will provide...
This $385,816 Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research) will fund the development and testing of "MIRAME SALUD", a culturally and linguistically tailored digital health platform to deliver immersive, interactive diabetes self-management training programs for Latino Americans. The award recipient, See Yourself Health LLC, a woman-owned small business, will leverage their...
This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $325,000 to Kairos Research LLC, a small disadvantaged business in Dayton, OH, to develop a mobile application to help Latino adolescents manage type 1 diabetes. The key products and services to be delivered under this 1-year award include optimizing the app design through end user research and internal testing (Aim 1), as well as...
The federal Project Grant award titled "THE PATHWAYS PROJECT: COMMUNITY LEVEL INNOVATIONS FOR IMPROVING DIABETES HEALTH OUTCOMES" is funded by the U.S. Department of Health and Human Services (HHS) Office of Minority Health under the Community Programs to Improve Minority Health Grant Program (CFDA 93.137). The $1,200,000 award, with a project period from Sep 1, 2024 to Aug 31, 2028, supports public and private evidence-based interventions and innovative models designed to improve...
Cognitopia Inc. received a $100,000 Project Grant award from the Department of Health and Human Services Administration for Community Living on September 1, 2021 to develop a person-centered approach to diabetes self-management for individuals with intellectual and developmental disabilities. The funding supports this work through May 31, 2022 under the ACL National Institute on Disability, Independent Living, and Rehabilitation Research program (CFDA #93.433). This program aims to improve the...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund the development and evaluation of the Diabetes Homeless Medication Support (D-HOMES) program. D-HOMES is a tailored behavioral support intervention aimed at improving diabetes medication adherence and glycemic control among adults living with type 2 diabetes who have...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to B.A. Maze, Inc. for $811,228 aims to advance the design and development of the At-Home Health Station (AHS) system. The AHS is a plug-and-play, modular technology platform that simplifies digital experiences for individuals with cognitive impairment or Alzheimer's disease and related dementias (CI/ADRD). The goal is to enable long-term independence and health for this population through remote patient...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $200,000.00 in funding to Boston Medical Center Corporation (BMC) to implement and assess the THRIVE-DM intervention. THRIVE-DM aims to maximize the proportion of type 2 diabetes mellitus (T2DM) patients with health-related social needs (HRSN) who successfully connect to and utilize social services to improve their T2DM outcomes....
This federal Project Grant award of $772,848, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to develop and evaluate an innovative, adaptive mobile phone-delivered intervention tailored to the social contexts of adults living with type 2 diabetes. The primary awardee, Vanderbilt University Medical Center, will enroll 405 adults with type 2...
THE HOPE APP: AN IMMERSIVE TELEHEALTH SOLUTION FOR OLDER ADULTS WITH DIABETES - TYPE 2 DIABETES (T2DM) IS AN EPIDEMIC. AN ESTIMATED 34 MILLION PEOPLE IN THE US HAVE T2DM AND 84 MILLION HAVE PRE-DIABETES - NEARLY HALF OF WHOM ARE ADULTS 65+ YO, PUTTING MANY OLDER ADULTS AT HIGHER RISK OF UNHEALTHY AGING AND COGNITIVE DECLINE. A HEALTHY LIFESTYLE CAN TREAT AND EVEN REVERSE T2DM. BUT MAKING LIFESTYLE CHANGES IS HARD AND MANY PEOPLE FAIL, CONTRIBUTING TO $327B IN US HEALTHCARE COSTS. DIABETES GROUP VISITS (DGV) AND DIABETES SELF- MANAGEMENT EDUCATION AND SUPPORT (DSME/S) HELP PEOPLE WITH T2DM TO LEARN AND SUSTAIN COMPLEX DISEASE MANAGEMENT SKILLS. YET, ACCESS TO DSME/S IS LIMITED SUCH PARTICIPATION IN DSME/S PROGRAMS IS REPORTEDLY AS LOW AS 7% AMONG ADULTS WITH T2DM. NEW TECHNOLOGIES SUPPORTING DSME/S PROGRAMS ARE EMERGING, BUT MOST FAIL TO MEET THE UNIQUE NEEDS OF OLDER ADULTS WITH LIMITED TECHNOLOGY FLUENCY, CREATING A NEW DIGITAL DIVIDE. SEE YOURSELF HEALTH (SYH) AIMS TO BRIDGE THIS DIGITAL HEALTH GAP FOR OLDER ADULTS WITH A NEWLY DESIGNED IMMERSIVE LEARNING AND TELEHEALTH APPLICATION - THE HOPE APP - DESIGNED TO DELIVER HIGH-IMPACT, HIGH ENGAGEMENT DIABETES CARE AND DSME/S TAILORED FOR OLDER ADULTS WITH DIABETES. ADVANCEMENTS IN VIRTUAL REALITY SOFTWARE, NEW CLOUD GAMING TECHNOLOGY AND USER INTERFACE DESIGN HAVE ENABLED OUR TEAM TO ENVISION A NEW TELEHEALTH AND IMMERSIVE LEARNING ENVIRONMENT TO SUPPORT CHRONIC DISEASE SELF- MANAGEMENT NEEDS OF OLDER ADULTS WITH DIABETES. WE USE VIRTUAL REALITY, TELECOMMUNICATION TECHNOLOGY AND SOCIAL GAMING STRATEGIES TO OFFER REAL-TIME PEER SUPPORT, CARE COACHING, AND 28 MODULES OF LIVE-ACTION EXPERIENTIAL LEARNING PROGRAMS TO HELP PARTICIPANTS MASTER COMPLEX DIABETES SELF-MANAGEMENT SKILLS. IN OUR PHASE I SBIR PROJECT, WE REACHED THE FOLLOWING MILESTONES: PROTOTYPED THE HOPE APP PLATFORM WITH CLOUD ACCESS AND NEW NAVIGATION AND COMMUNICATION FEATURES; COMPLETED USABILITY TESTING (SUS = 71) WITH 20 TARGET USERS AND FEASIBILITY TESTING (100% PARTICIPATION) OF THE HOPE APP PLATFORM; DEVELOPED NEW DSME CONTENT FOR OLDER ADULTS. IN PHASE II, WE WILL FURTHER DEVELOP THE HOPE APP PATIENT ENGAGEMENT AND POPULATION HEALTH MANAGEMENT FEATURES AND CAPABILITIES AND THEN ASSESS ITS EFFICACY IN A FULLY POWERED CLINICAL TRIAL. SPECIFIC AIM 1: DEVELOP THE HOPE APP'S STATE-OF-THE-ART IMMERSIVE PATIENT ENGAGEMENT EXPERIENCE WITH AUTOMATED ONBOARDING, SOCIAL NETWORKING AND GAMIFIED DSME/S FEATURES TO SUPPORT LONG-TERM PATIENT RETENTION. SPECIFIC AIM 2: DEVELOP THE HOPE APP'S PREDICTIVE ANALYTIC CAPABILITIES FOR POPULATION HEALTH MANAGEMENT. SPECIFIC AIM 3: CLINICAL VALIDATION OF THE HOPE APP INTERVENTION ON SIX-MONTH CLINICAL OUTCOMES (A1C), PATIENT REPORTED OUTCOMES (DIABETES DISTRESS) AND ENGAGEMENT (PATIENT RETENTION, ADHERENCE TO DSME/S). SYH HAS ASSEMBLED AN EXPERT BUSINESS TEAM TO SELL THE HOPE APP TO OUR TARGET CUSTOMER, HEALTH CARE PAYORS. THE HOPE APP OFFERS A SIMPLE, HIGH- IMPACT, HIGHLY ENGAGING, IMMERSIVE TELEHEALTH EXPERIENCE WITH THE POTENTIAL TO BECOME A UBIQUITOUS DIABETES MANAGEMENT TOOL TO TRANSFORM DIABETES PATIENTS INTO HIGH PERFORMING DRIVERS OF THEIR OWN CARE.